A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma

Martin Dreyling, Constantine S. Tam, Michael Wang, Stephen D. Smith, Marco Ladetto, Huiqiang Huang, William Novotny, Melannie Co, Alfredo Romano, Eric Holmgren, Jane Huang, Steven Le Gouill

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences